X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3928) 3928
female (3827) 3827
science & technology (3021) 3021
life sciences & biomedicine (2960) 2960
ovarian neoplasms - pathology (2460) 2460
middle aged (2343) 2343
cystadenocarcinoma, serous - pathology (2334) 2334
aged (1881) 1881
oncology (1795) 1795
adult (1704) 1704
ovarian cancer (1187) 1187
neoplasm staging (1184) 1184
prognosis (1141) 1141
obstetrics & gynecology (1080) 1080
cystadenocarcinoma, serous - genetics (916) 916
cystadenocarcinoma, serous - metabolism (884) 884
ovarian neoplasms - genetics (879) 879
aged, 80 and over (833) 833
ovarian neoplasms - metabolism (811) 811
pathology (795) 795
cancer (732) 732
immunohistochemistry (729) 729
retrospective studies (653) 653
endometrial neoplasms - pathology (589) 589
cystadenocarcinoma, serous - surgery (573) 573
survival rate (568) 568
cystadenocarcinoma, serous - drug therapy (535) 535
follow-up studies (526) 526
ovarian neoplasms - drug therapy (511) 511
cystadenocarcinoma, serous - mortality (506) 506
adenocarcinoma, clear cell - pathology (496) 496
ovarian neoplasms - mortality (458) 458
ovarian neoplasms - surgery (457) 457
neoplasm grading (440) 440
adenocarcinoma, mucinous - pathology (401) 401
cystadenocarcinoma, papillary - pathology (378) 378
chemotherapy (375) 375
surgery (375) 375
carcinoma, endometrioid - pathology (357) 357
cystadenocarcinoma, serous - diagnosis (355) 355
cystadenocarcinoma, serous - secondary (326) 326
biomarkers, tumor - metabolism (322) 322
carcinoma (317) 317
tumors (312) 312
antineoplastic combined chemotherapy protocols - therapeutic use (309) 309
diagnosis, differential (307) 307
gene expression regulation, neoplastic (304) 304
analysis (298) 298
ovarian neoplasms - diagnosis (290) 290
cystadenocarcinoma - pathology (284) 284
treatment outcome (282) 282
neoplasm invasiveness (276) 276
ovarian carcinoma (274) 274
male (270) 270
young adult (268) 268
research (260) 260
peritoneal neoplasms - pathology (259) 259
mutation (255) 255
neoplasm recurrence, local - pathology (255) 255
cell line, tumor (247) 247
gene expression (242) 242
animals (236) 236
cystadenocarcinoma, serous - therapy (235) 235
cystadenocarcinoma, mucinous - pathology (232) 232
biomarkers, tumor - analysis (229) 229
uterine neoplasms - pathology (229) 229
ovary (228) 228
obstetrics and gynecology (227) 227
survival analysis (227) 227
adolescent (226) 226
metastasis (222) 222
endometrial cancer (218) 218
immunoenzyme techniques (218) 218
tumor cells, cultured (218) 218
disease-free survival (217) 217
lymphatic metastasis (217) 217
care and treatment (215) 215
genetic aspects (212) 212
hematology, oncology and palliative medicine (202) 202
combined modality therapy (200) 200
fallopian tube neoplasms - pathology (199) 199
biomarkers, tumor - genetics (195) 195
ovarian neoplasms - therapy (189) 189
endometrial neoplasms - surgery (187) 187
medicine & public health (187) 187
mice (183) 183
risk factors (183) 183
adenocarcinoma, clear cell - mortality (181) 181
cell biology (180) 180
adenocarcinoma, clear cell - metabolism (179) 179
adenocarcinoma, clear cell - surgery (177) 177
endocrine system diseases (175) 175
endometrial neoplasms - metabolism (174) 174
health aspects (172) 172
neoplasms, glandular and epithelial - pathology (172) 172
endometrial neoplasms - mortality (171) 171
adenocarcinoma - pathology (170) 170
carcinoma, ovarian epithelial (167) 167
case-control studies (165) 165
chemotherapy, adjuvant (165) 165
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3763) 3763
Chinese (187) 187
Japanese (75) 75
German (45) 45
French (33) 33
Russian (25) 25
Polish (11) 11
Spanish (10) 10
Italian (7) 7
Hungarian (4) 4
Bulgarian (3) 3
Danish (3) 3
Romanian (3) 3
Czech (2) 2
Hebrew (2) 2
Dutch (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gynecologic oncology, ISSN 0090-8258, 11/2016, Volume 143, Issue 2, pp. 433 - 438
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 11, p. e80063
...). Our study sought to investigate the association of tumor-infiltrating CD4(+)CD25(+)FOXP3(+) Tregs, and other immune factors, with clinical outcome in serous ovarian cancer patients... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | CD8-Positive T-Lymphocytes - pathology | Prognosis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - genetics | Ovarian Neoplasms - mortality | CD4-Positive T-Lymphocytes - pathology | Cystadenocarcinoma, Serous - pathology | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Ovarian Neoplasms - genetics | Interleukin-2 Receptor alpha Subunit - genetics | Aged, 80 and over | Adult | Female | Cystadenocarcinoma, Serous - immunology | Interleukin-2 Receptor alpha Subunit - immunology | Gene Expression | Ovary - pathology | Ovary - immunology | Immunophenotyping | Survival Analysis | Cystadenocarcinoma, Serous - mortality | Lymphocyte Count | Aged | CD8-Positive T-Lymphocytes - immunology | Forkhead Transcription Factors | Ovarian Neoplasms - immunology | Transcription factors | Ovarian carcinoma | CD8 antigen | Effector cells | Cytotoxicity | Lymphocytes T | Malignancy | Clinical outcomes | Ovarian cancer | Immunology | Lymphocytes | Immunotherapy | CD25 antigen | Foxp3 protein | Cell survival | Immunoregulation | Histology | CD3 antigen | Patients | Survival | CD4 antigen | Studies | Chemotherapy | Medical prognosis | Immunofluorescence | Cancer | Tumors
Journal Article
Journal Article
The Journal of pathology, ISSN 0022-3417, 12/2013, Volume 231, Issue 4, pp. 449 - 456
Journal Article